Patent · US Active

Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans

US7335666B2 · kind B2 · utility

0Cited by
2References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2006
Grant dateFeb 26, 2008
Priority date—
Expiry dateAug 31, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the Formula:are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.